These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19195813)

  • 1. Management practices in substance abuse treatment programs.
    McConnell KJ; Hoffman KA; Quanbeck A; McCarty D
    J Subst Abuse Treat; 2009 Jul; 37(1):79-89. PubMed ID: 19195813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of an abstinence-oriented, outpatient drug addiction service in Greece.
    Paparrigopoulos T; Liappas J; Mellos E; Rabavilas A
    Psychol Rep; 2007 Jun; 100(3 Pt 1):1024-42. PubMed ID: 17688121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mangement of drug problems in Hungary].
    Buda B
    Lege Artis Med; 2009 Sep; 19(8-9):537-41. PubMed ID: 20608432
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance contracting and quality improvement in outpatient treatment: effects on waiting time and length of stay.
    Stewart MT; Horgan CM; Garnick DW; Ritter G; McLellan AT
    J Subst Abuse Treat; 2013 Jan; 44(1):27-33. PubMed ID: 22445031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the benefits of addiction treatment: practical strategies for continuing care and recovery.
    McKay JR; Carise D; Dennis ML; Dupont R; Humphreys K; Kemp J; Reynolds D; White W; Armstrong R; Chalk M; Haberle B; McLellan T; O'Connor G; Pakull B; Schwartzlose J
    J Subst Abuse Treat; 2009 Mar; 36(2):127-30. PubMed ID: 19161893
    [No Abstract]   [Full Text] [Related]  

  • 6. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Holtmann M; Thomasius R; Melchers P; Klein M; Schimansky G; Krömer T; Reis O
    Z Kinder Jugendpsychiatr Psychother; 2018 Mar; 46(2):173-181. PubMed ID: 29521187
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving consistency and quality of service delivery: implications for the addiction treatment field.
    Knott AM; Corredoira R; Kimberly J
    J Subst Abuse Treat; 2008 Sep; 35(2):99-108. PubMed ID: 18082996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and validation of a transformational leadership survey for substance use treatment programs.
    Edwards JR; Knight DK; Broome KM; Flynn PM
    Subst Use Misuse; 2010 Jul; 45(9):1279-302. PubMed ID: 20509734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of organization and management in substance abuse treatment: Review and roadmap.
    D'Aunno T
    J Subst Abuse Treat; 2006 Oct; 31(3):221-33. PubMed ID: 16996385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the organization, management, and outcomes of substance abuse treatment programs.
    Heinrich CJ; Lynn LE
    Am J Drug Alcohol Abuse; 2002 Nov; 28(4):601-22. PubMed ID: 12492259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managed care and outpatient substance abuse treatment intensity.
    Lemak CH; Alexander JA
    J Behav Health Serv Res; 2001 Feb; 28(1):12-29. PubMed ID: 11329996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A system-level study of initiation, engagement, and equity in outpatient substance use treatment.
    Urbanoski K; Kenaszchuk C; Inglis D; Rotondi NK; Rush B
    J Subst Abuse Treat; 2018 Jul; 90():19-28. PubMed ID: 29866380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A performance measure for continuity of care after detoxification: relationship with outcomes.
    Lee MT; Horgan CM; Garnick DW; Acevedo A; Panas L; Ritter GA; Dunigan R; Babakhanlou-Chase H; Bidorini A; Campbell K; Haberlin K; Huber A; Lambert-Wacey D; Leeper T; Reynolds M
    J Subst Abuse Treat; 2014 Aug; 47(2):130-9. PubMed ID: 24912862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a statewide evaluation of "paperwork burden" in addiction treatment.
    Carise D; Love M; Zur J; McLellan AT; Kemp J
    J Subst Abuse Treat; 2009 Jul; 37(1):101-9. PubMed ID: 19150201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse treatment programs' data management capacity: an exploratory study.
    Wisdom JP; Ford JH; Wise M; Mackey D; Green CA
    J Behav Health Serv Res; 2011 Apr; 38(2):249-64. PubMed ID: 20574647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent-only substance abuse treatment: availability and adoption of components of quality.
    Knudsen HK
    J Subst Abuse Treat; 2009 Mar; 36(2):195-204. PubMed ID: 19000942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organizational change required for paradigmatic shift in addiction treatment.
    Hamm FB
    J Subst Abuse Treat; 1992; 9(3):257-60. PubMed ID: 1334158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing evidence-based practices into substance abuse treatment using organization development methods.
    Amodeo M; Ellis MA; Samet JH
    Am J Drug Alcohol Abuse; 2006; 32(4):555-60. PubMed ID: 17127543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.